E. Dale Abel

Evan Dale Abel (born 1963) is an American endocrinologist who serves as chair of the Department of Medicine at the David Geffen School of Medicine at UCLA. His works on the molecular mechanisms that underpin cardiac failure in diabetes. He is a fellow of the American Heart Association and the American College of Physicians. He was elected a member of the National Academy of Sciences in 2022.

Early life and education Abel was born on February 4, 1963, in Jamaica, where he attended Wolmer's High School for Boys. He was encouraged by his parents to become a doctor, lawyer or engineer.

Research and career Abel started a clinical research fellowship in diabetes at Harvard Medical School in 1992. He then joined the faculty at Harvard, where he was appointed co-director of the fellowship programme at Beth Israel Deaconess Medical Center. He made use of conditional gene targeting to induce genetic defects that resulted in heart muscle cells being incapable of taking up glucose. His works on the molecular mechanisms that underpin cardiac failure in diabetes.

In 2022 Abel moved to the University of California, Los Angeles as chair of the Department of Medicine in the David Geffen School of Medicine at UCLA.

Awards and honors 1986: Rhodes Scholarship at the University of Oxford 1996: Harvard Medical School Eleanor and Miles Shore, 50th Anniversary Scholars in Medicine Fellowship 1999: Harvard Medical School Excellence in Teaching Award 2001: David W. Haack Memorial Award in Cardiovascular Research 2012: Meharry Medical College James Pulliam Memorial Lectureship 2018: NIH Director's Astute Clinician Lecture 2018: African American Museum of Iowa History Makers Award 2020: Selected as president-elect of the Association of Professors of Medicine 2020: Named by Cell Press as one of the most inspirational Black scientists in the United States 2023: Fred Conrad Koch Lifetime Achievement Award, the Endocrine Society's highest award, for his significant impact on endocrinology

Selected publications